Search

Hua I Tu

from San Carlos, CA
Age ~52
Get Report
Also known as:
Hua Vickie Tu, Tu I Hua
Phone and address:
1550 Brittan Ave, San Carlos, CA 94070
Related to:
Tu HaoVickie Sun, 52Yi Pu Tu, 96Wen Tu, 65Li P Sun, 85Qi Sun Hui, 52Hao TuJun Yong Sun, 85Karen H Zhong, 60Yipu Tu, 96
Connected to:
Amanda Tu, 32Ashley Tu, 31Bernard R Tu, 50Chin C Tu, 50Chong Tu, 42Chuck Tu, 71Cuong V Tu, 56Dale Tu, 44Dean N Tu, 50Di K Tu, 50

Hua Tu Phones & Addresses

  • 1550 Brittan Ave, San Carlos, CA 94070
  • Flower Mound, TX
  • Hayward, CA
  • Nampa, ID
  • San Bruno, CA
  • Huntington, NY
  • San Mateo, CA
  • Alameda, CA
  • Port Washington, NY

Resumes

Resumes

Hua Tu Photo 1

Founder And Ceo Of Lakepharma

View page
Location:
San Francisco Bay Area
Industry:
Biotechnology
Hua Tu Photo 2

Chairman And Chief Executive Officer

View page
Location:
San Francisco, CA
Industry:
Biotechnology
Work:
LakePharma, Inc. - Belmont, CA since 2009
Founder and CEO
Amgen 2006 - 2009
Principal Scientist
Amgen - South San Francisco, CA 2004 - 2006
Senior Scientist
Tularik - South San Francisco, CA May 1998 - Aug 2004
Scientist
Education:
Cold Spring Harbor Laboratory 1994 - 1998
State University of New York at Stony Brook 1994 - 1998
Ph.D., Molecular and Cell Biology State University of New York at Stony Brook 1993 - 1994
BS, Biochemistry (Honors) Wuhan University 1990 - 1992
Skills:
Biotechnology
Drug Development
Protein Chemistry
Antibodies
Drug Discovery
Molecular Biology
Biochemistry
Biopharmaceuticals
Cell Culture
Protein Engineering
Cell Biology
Protein Expression
In Vitro
Biomarker Discovery
Pharmaceutical Industry
Assay Development
Cell
Protein Purification
In Vivo
Purification
Lifesciences
Small Molecules
Genomics
Clinical Research
Diabetes
Immunology
Monoclonal Antibodies
Languages:
Mandarin
Hua Tu Photo 3

Hua Tu

View page
Location:
United States

Business Records

Name / Title
Company / Classification
Phones & Addresses
Hua Tu
CEO, President
LakePharma, Inc.
Biotechnology · Mfg Biological Products · Business Services at Non-Commercial Site · Consulting
530 Hbr Blvd, Belmont, CA 94002
1550 Brittan Ave, San Carlos, CA 94070
(650) 453-3460

Publications

Us Patents

Diaza Heterocyclic Sulfonamide Derivatives And Their Uses

View page
US Patent:
7825122, Nov 2, 2010
Filed:
Dec 13, 2006
Appl. No.:
11/637932
Inventors:
Jay P. Powers - Pacifica CA, US
Xuelei Yan - Foster City CA, US
Daqing Sun - Foster City CA, US
Hua Tu - San Carlos CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/497
A61K 31/4965
C07D 403/04
C07D 401/04
US Classification:
51425216, 544295, 544360, 544383, 51425301, 51425503
Abstract:
Diaza heterocyclic sulfonamide derivatives according to formula I have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorders:.

Treatment Of Hypertriglyceridemia And Other Conditions Using Lxr Modulators

View page
US Patent:
20020048572, Apr 25, 2002
Filed:
May 3, 2001
Appl. No.:
09/848990
Inventors:
Bei Shan - Redwood City CA, US
Joshua Schultz - Half Moon Bay CA, US
Hua Tu - San Bruno CA, US
International Classification:
A61K038/43
A61K031/58
US Classification:
424/094100, 514/172000
Abstract:
This invention provides methods for identifying compounds that are suitable for use in modulating fatty acid and triglyceride biosynthesis, and thus treating conditions such as hypertriglyceridemia and lipodystrophy, among others. Provided are in vitro assays by which one can conduct prescreening to identify candidate therapeutic agents that are suitable for further testing, as well as assays for identifying agents that are useful for administration for treating conditions associated with abnormalities in fatty acid and triglyceride biosynthesis.

Pyrazole Compounds And Uses Related Thereto

View page
US Patent:
20080161374, Jul 3, 2008
Filed:
Feb 14, 2008
Appl. No.:
12/071038
Inventors:
Hiroyuki Goto - Osaka, JP
Makoto Kakutani - Osaka, JP
Jun Nishiu - Osaka, JP
Yasuhiro Ohe - Osaka, JP
Jay P. Powers - Pacifica CA, US
Shinji Yata - Osaka, JP
Hua Tu - San Carlos CA, US
International Classification:
A61K 31/4184
C07D 231/10
A61K 31/415
A61P 43/00
A61P 3/10
A61P 3/04
A61P 3/00
US Classification:
514393, 5483731, 514406
Abstract:
Substituted pyrazoles are provided that are useful for the treatment of, for example, diabetes, obesity and metabolic syndrome.

Surface Markers And Uses Thereof For Rapid Stable Cell Line Generation And Gene Amplification

View page
US Patent:
20130130385, May 23, 2013
Filed:
May 6, 2011
Appl. No.:
13/696586
Inventors:
Hua Tu - San Carlos CA, US
International Classification:
C12N 15/65
US Classification:
435455, 4353201
Abstract:
The present invention provides methods of producing recombinant cells, methods of large scale production of a gene expression product (such as protein), and methods of establishing a stable cell line using the surface markers. Also provided are expression vectors encoding the surface markers and cells comprising the expression vectors. Further provided are gene expression products (such as proteins) and cells obtained using methods described herein, as well as kits useful for carrying out methods described herein.

Pyrazole Compounds And Uses Related Thereto

View page
US Patent:
7354938, Apr 8, 2008
Filed:
Mar 18, 2005
Appl. No.:
11/084734
Inventors:
Hiroyuki Goto - Takatsuki, JP
Makoto Kakutani - Takatsuki, JP
Jun Nishiu - Takatsuki, JP
Yasuhiro Ohe - Takatsuki, JP
Jay P. Powers - Pacifica CA, US
Shinji Yata - Takatsuki, JP
Hua Tu - San Carlos CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/4439
C07D 401/04
US Classification:
514341, 5462754
Abstract:
Substituted pyrazoles are provided that are useful for the treatment of, for example, diabetes, obesity and metabolic syndrome.

Sars-Cov-2 Spike Protein Antibodies

View page
US Patent:
20220372114, Nov 24, 2022
Filed:
May 17, 2022
Appl. No.:
17/746768
Inventors:
- Albany NY, US
Dan LUO - Newark CA, US
Ling ZHANG - Menlo Park CA, US
Vydehi KANNEGANTI - Hayward CA, US
Joyce YU - Menlo Park CA, US
Sophie YANG - Mountain View CA, US
Lequn ZHAO - San Francisco CA, US
Hua TU - Flower Mound TX, US
International Classification:
C07K 16/10
A61P 31/14
Abstract:
The present disclosure provides antibodies that bind to the SARS-CoV-2 spike protein, as well as compositions containing the same, and methods of making and using such a composition for treating, preventing, and/or detecting SARS-CoV-2 infection.

Sars-Cov-2 Spike Protein Antibodies

View page
US Patent:
20230115257, Apr 13, 2023
Filed:
May 17, 2022
Appl. No.:
17/746859
Inventors:
- Albany NY, US
Dan LUO - Newark CA, US
Ling ZHANG - Menlo Park CA, US
Vydehi KANNEGANTI - Hayward CA, US
Joyce YU - Menlo Park CA, US
Sophie YANG - Mountain View CA, US
Lequn ZHAO - c/o Curia IP Holdings, LLC CA, US
Hua TU - Flower Mound TX, US
Xiaomei GE - Foster City CA, US
International Classification:
C07K 16/10
G01N 33/569
Abstract:
Embodiments include monoclonal antibodies (mAbs) that recognize SARS-Cov-2 spike protein. The mAbs are capable of distinguishing among variants of the virus. The present disclosure also provides a composition and methods of making and using such a composition for treating, preventing, and/or detecting SARS-CoV-2 infection.
Control profile
Hua I Tu from San Carlos, CA, age ~52 Get Report